Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $35.4B
1-Year Est. Return 17.05%
This Quarter Est. Return
1 Year Est. Return
+17.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$31.7B
AUM Growth
+$976M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
683
New
Increased
Reduced
Closed

Top Buys

1 +$328M
2 +$325M
3 +$253M
4
TMO icon
Thermo Fisher Scientific
TMO
+$180M
5
USB icon
US Bancorp
USB
+$129M

Top Sells

1 +$129M
2 +$128M
3 +$90.4M
4
GSK icon
GSK
GSK
+$78M
5
DGX icon
Quest Diagnostics
DGX
+$44.4M

Sector Composition

1 Technology 29.69%
2 Healthcare 26%
3 Financials 11.57%
4 Communication Services 9.28%
5 Consumer Discretionary 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
651
-3,254
652
-218,200
653
-16,662
654
-72,375
655
-560,159
656
-260,452
657
-39,243
658
-17,755
659
-28,662
660
-11,921
661
-1,645,467
662
-348,323
663
-2,641
664
-5,524
665
-21,145
666
-9,229
667
-4,511
668
-4,164
669
-11,266
670
-421,744
671
-50,473
672
-9,295
673
-10,289
674
-5,873
675
-146,419